http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060011305-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4382d8c7d59b830faa7ccec0acf2b8e4
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-12004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-418
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-06166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12195
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-12
filingDate 2004-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a83bad21dbb597d187dd5964a0469b58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba968bb15e3034804271ebbd5f3af786
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb9f6fba19a2824a0687ae930992fe21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27dcdc213b23a448b825a3e06ae494b3
publicationDate 2006-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20060011305-A
titleOfInvention Vascular tourniquet
abstract After medical treatment through blood vessels of the human body, hemostasis treatment can be performed quickly in response to perforation of blood vessels. Especially, hemostasis is performed because hemostasis treatment and action is performed only in the perforated passage section without occupying any vessel passage. It is easy to process and can prevent medical side effects, such as through the blood vessels, and relates to vascular hemostatic cells that can obtain more improved surgical stability and hemostatic quality.n n n The vascular hemoglobin is a vascular hemoglobin that forms a physical barrier layer to allow hemostasis treatment and function only within the perforated passage section between the skin and the blood vessel without occupying the passage of the blood vessel during the hemostatic treatment of the blood vessel,n n n Guide the hemoglobin body which is inserted in a state capable of blocking this section in response to the perforated passage section for hemostasis of blood vessels, and guide the hemoglobin body in a posture capable of hemostasis treatment and action by a locking action on the perforated passageway It includes a locking means for,n n n The locking means may include an anchor providing a support area for a locking action corresponding to the hemoglobin body, and an excessive insertion state of the hemoglobin body outside the perforated passage so that the locking action may be connected to the anchor side. It includes a string member for adjusting.n n n n Improving the body's blood vessels, hemostatic treatment, and the space for the procedure, the passages perforated on the vessel side, the hemoglobin body, the locking means, the anchors, the string members, the sutures, the biodegradable materials, the gelatin, the collagen, the chitosan, the stability of the procedure, and the quality of the hemostasis
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190038462-A
priorityDate 2004-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439199
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966231
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426120401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24846132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5102882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417109324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID757
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450984220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6850753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407364031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227

Total number of triples: 47.